Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Baird Maintains Neutral on Duluth Holdings, Lowers Price Target to $9

Baird analyst Jonathan Komp maintains Duluth Holdings (NASDAQ:DLTH) with a Neutral and lowers the price target from $11 to $9.
byBenzinga Newsdesk
September 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Baird analyst Jonathan Komp maintains Duluth Holdings (NASDAQ:DLTH) with a Neutral and lowers the price target from $11 to $9.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Bio-Rad And Nuprobe Enter Into An Exclusive Licensing Agreement For Digital PCR Applications; Nuprobe USA To Exclusively License Its Allele Enrichment Technologies To Co For Development Of Multiplexed Digital PCR Assays

By Benzinga Newsdesk
November 7, 3:34 PM
Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, today announced the signing of a licensing

BIO